Reference

Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection

Du, Y. X., & Chen, X. P. (2020). Favipiravir: pharmacokinetics and concerns about clinical trials for 2019‐nCoV infection. Clinical Pharmacology & Therapeutics.

https://doi.org/10.1002/cpt.1844 https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.1844

0

1

Updated 2020-08-12

Contributors are:

Who are from:

Tags

SARS-CoV-2 (COVID-19)

Biomedical Sciences